Invasive Breast Lobular Carcinoma: Clinical Trials

3 trials for Invasive Breast Lobular Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Recruiting 1
Phase 22Recruiting 2

Follow Invasive Breast Lobular Carcinoma: new trials by email Literature Review of Invasive Breast Lobular Carcinoma trials Research Report on Invasive Breast Lobular Carcinoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers
Endocrine Therapy, Biopsy of breast, Neratinib - Anatomic Stage I Breast Cancer, Anatomic Stage II Breast Cancer
Phase 2RecruitingVanderbilt-Ingram Cancer Center302024-06-112026-08-19
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Cyclophosphamide, Neoantigen Peptide Vaccine, Pembrolizumab - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Phase 1 / Phase 2RecruitingMayo Clinic1382022-03-312026-08-20
Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer
Computed Tomography, Fluciclovine F18, Gallium Ga 68 Gozetotide - Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Lobular Carcinoma
Phase 1CompletedEmory University202021-07-162025-01-17

Narrower conditions

Carcinoma, Lobular (3)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Merkel Cell (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Renal Cell (1)  ·  Carcinoma, Transitional Cell (1)  ·  Carcinosarcoma (1)  ·  Endometrial Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Melanoma (1)  ·  Neoplasm Metastasis (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Triple Negative Breast Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)

Broader conditions

Adenocarcinoma (3)  ·  Breast Diseases (3)  ·  Breast Neoplasms (3)  ·  Carcinoma (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms by Site (3)  ·  Neoplasms, Ductal, Lobular, and Medullary (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Skin Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Carcinoma, Neuroendocrine (1)  ·  Carcinoma, Squamous Cell (1)

Interventions

Magnetic Resonance Spectroscopy (3)  ·  68Ga-DKFZ-PSMA-11 (1)  ·  Biopsy (1)  ·  Colony-Stimulating Factors (1)  ·  Cyclophosphamide (1)  ·  High-Energy Shock Waves (1)  ·  Immunoglobulin G (1)  ·  Mastectomy, Segmental (1)  ·  Specimen Handling (1)  ·  X-Rays (1)  ·  fluciclovine F-18 (1)  ·  gallium 68 PSMA-11 (1)  ·  neratinib (1)  ·  pembrolizumab (1)  ·  sargramostim (1)

Sponsors

Emory University (1)  ·  Mayo Clinic (1)  ·  Vanderbilt-Ingram Cancer Center (1)

Countries

United States (3)

Top investigators

David M Schuster, MD (1)  ·  Laura Kennedy, MD, PhD (1)  ·  Yanyan Lou, MD, PhD (1)

Results publications

PMID 38976035

NIH funding

P30CA138292 (1), R01CA273246 (1)